User profiles for Jacopo Vannucci

Jacopo Vannucci

Sapienza University of Rome
Verified email at uniroma1.it
Cited by 1217

[HTML][HTML] Expert consensus on resection of chest wall tumors and chest wall reconstruction

…, A Sandri, Z Sziklavari, J Vannucci… - … lung cancer research, 2021 - ncbi.nlm.nih.gov
Chest wall tumors are a relatively uncommon disease in clinical practice. Most of the published
studies about chest wall tumors are usually single-center retrospective studies, involving …

[HTML][HTML] Kynurenine/tryptophan ratio as a potential blood-based biomarker in non-small cell lung cancer

…, E Orecchini, G Bellezza, J Vannucci… - International journal of …, 2021 - mdpi.com
The enzyme indoleamine 2,3-dioxygenase 1 (IDO1) degrade tryptophan (Trp) into kynurenine
(Kyn) at the initial step of an enzymatic pathway affecting T cell proliferation. IDO1 is …

Epidemiology and management of primary spontaneous pneumothorax: a systematic review

P Mendogni, J Vannucci, M Ghisalberti… - … and thoracic surgery, 2020 - academic.oup.com
Jacopo Vannucci , Jacopo VannucciJacopo Vannucci, Marco Ghisalberti, MarcoAnile
and Beatrice Aramini contributed equally to this study. …

[HTML][HTML] Dyskerin and TERC expression may condition survival in lung cancer patients

M Penzo, V Ludovini, D Treré, A Siggillino, J Vannucci… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Dyskerin mediates both the modification of uridine on ribosomal and small nuclear RNAs
and the stabilization of the telomerase RNA component (TERC). In human tumors dyskerin …

[HTML][HTML] Indoleamine 2, 3-dioxygenase 2 immunohistochemical expression in resected human non-small cell lung cancer: a potential new prognostic tool

…, G Bellezza, ML Belladonna, J Vannucci… - Frontiers in …, 2020 - frontiersin.org
Indoleamine 2,3-dioxygenase 2 (IDO2) is an analog of the tryptophan degrading and
immunomodulating enzyme indoleamine 2,3-dioxygenase 1 (IDO1). Although the role of IDO1 is …

Thyroid cancer invading the airway: diagnosis and management

N Avenia, J Vannucci, M Monacelli… - … Journal of Surgery, 2016 - journals.lww.com
Methods: Retrospective study of 30 years experience in thyroid surgery for cancer invading
airway. Clinical records, surgical and pathology reports have been analyzed to assess which …

[HTML][HTML] Chest wall resection and reconstruction for tumors: analysis of oncological and functional outcome

…, S Ceccarelli, F Puma, J Vannucci - Journal of Thoracic …, 2018 - ncbi.nlm.nih.gov
Background Tumors of the chest wall have a large spectrum of well-assessed indications for
resection. However, whether a reconstruction is required or not is not always clear. …

Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications

…, BJ Van den Eynde, R Chiari, J Vannucci… - Virchows Archiv, 2019 - Springer
Several cancers, especially non-small cell lung cancer (NSCLC), are able to escape the
immunosurveillance of tumor-infiltrating lymphocytes (TILs); among the molecules involved, the …

[HTML][HTML] Clinical guidelines on perioperative management strategies for enhanced recovery after lung surgery

…, J Shen, H Tian, L Voltolini, J Vannucci… - … lung cancer research, 2019 - ncbi.nlm.nih.gov
The concept of enhanced recovery after surgery (ERAS) was first developed in Denmark in
1997 by Dr. Kehlet (1). ERAS is designed to optimize perioperative management, improve …

[HTML][HTML] Role of radiomics in predicting lung cancer spread through air spaces in a heterogeneous dataset

M Bassi, A Russomando, J Vannucci… - Translational Lung …, 2022 - ncbi.nlm.nih.gov
Background Spread through air spaces (STAS) has been reported as a negative prognostic
factor in patients with lung cancer undergoing sublobar resection. Radiomics has been …